HC Wainwright reaffirmed their buy rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. HC Wainwright currently has a $120.00 price objective on the stock. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $38.00 price objective on […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price traded up 6.9% during trading on Tuesday after the company announced better than expected quarterly earnings. The company traded as high as $51.78 and last traded at $51.68. 274,585 shares changed hands during mid-day trading, a decline of 77% from the average session volume of […]
Morgan Stanley restated their equal weight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report issued on Friday morning, Benzinga reports. The brokerage currently has a $42.00 target price on the stock. A number of other equities analysts have also commented on the stock. HC Wainwright reissued a buy rating and […]
Direct Digital (NASDAQ:DRCT – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, August 10th. Analysts expect Direct Digital to post earnings of $0.13 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. Direct Digital […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Investment analysts at William Blair boosted their Q3 2023 earnings estimates for Allogene Therapeutics in a research note issued on Thursday, August 3rd. William Blair analyst S. Corwin now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior […]